NIKKEI 225
29,255.55 +40.03 (+0.14%) HANG SENG
26,136.02 +348.81 (+1.35%) CRUDE OIL
84.25 +0.38 (+0.45%) GOLD FUTURES
1,783.00 -1.90 (-0.11%) DOW
35,609.34 +152.03 (+0.43%) BTC-GBP
47,770.70 +1,000.46 (+2.14%)
Inogen, Inc. (INGN)
After hours: 05:58PM EDT
| Previous close | 41.70 |
| Open | 41.87 |
| Bid | 41.77 x 800 |
| Ask | 42.20 x 800 |
| Day's range | 41.45 - 42.12 |
| 52-week range | 26.90 - 82.35 |
| Volume | 83,462 |
| Avg. volume | 196,424 |
| Market cap | 943.779M |
| Beta (5Y monthly) | 1.03 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.11 |
| Earnings date | 04 Nov 2021 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 71.00 |
- Business Wire
Inogen to Announce Third Quarter 2021 Financial Results on November 4, 2021
GOLETA, Calif., October 13, 2021--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release third quarter 2021 financial results after market close on Thursday, November 4, 2021. The Company will host a corresponding conference call beginning at 2:00pm PT/5:00pm ET.
- Business Wire
Inogen Appoints Stanislav Glezer as Chief Technology Officer
GOLETA, Calif., October 12, 2021--Inogen, Inc. (NASDAQ: INGN), ("Inogen" or "the Company"), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that Stanislav Glezer, MD has been appointed to the role of Chief Technology Officer responsible for R&D and Engineering, Medical Affairs, and Regulatory Affairs. Mr. Glezer will remain an Executive Vice President of the Company.
- Zacks
Here's Why You Should Retain Inogen (INGN) Stock For Now
Investors continue to be optimistic about Inogen (INGN) on its potential in the POC space and a strong product portfolio.
